Illumina Body Map 2, young vs old
Name | miRBASE accession |
---|---|
hsa-miR-137
|
MIMAT0000429 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_236849754 | 5.33 |
ENST00000542672.1
ENST00000366578.4 |
ACTN2
|
actinin, alpha 2 |
chr1_-_33338076 | 3.59 |
ENST00000496770.1
|
FNDC5
|
fibronectin type III domain containing 5 |
chr13_+_23755054 | 3.17 |
ENST00000218867.3
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) |
chr19_-_2721412 | 2.97 |
ENST00000323469.4
|
DIRAS1
|
DIRAS family, GTP-binding RAS-like 1 |
chr15_+_85359911 | 2.72 |
ENST00000258888.5
|
ALPK3
|
alpha-kinase 3 |
chr12_+_125811162 | 2.64 |
ENST00000299308.3
|
TMEM132B
|
transmembrane protein 132B |
chr11_+_109292846 | 2.55 |
ENST00000327419.6
|
C11orf87
|
chromosome 11 open reading frame 87 |
chr1_+_237205476 | 2.50 |
ENST00000366574.2
|
RYR2
|
ryanodine receptor 2 (cardiac) |
chr1_-_217262969 | 2.39 |
ENST00000361525.3
|
ESRRG
|
estrogen-related receptor gamma |
chr6_+_17281573 | 2.39 |
ENST00000379052.5
|
RBM24
|
RNA binding motif protein 24 |
chr8_-_124553437 | 2.39 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr19_-_11591848 | 2.32 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
chr11_-_18765389 | 2.23 |
ENST00000477854.1
|
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) |
chr17_-_37764128 | 2.23 |
ENST00000302584.4
|
NEUROD2
|
neuronal differentiation 2 |
chr1_-_119532127 | 2.20 |
ENST00000207157.3
|
TBX15
|
T-box 15 |
chr8_-_22014339 | 2.18 |
ENST00000306317.2
|
LGI3
|
leucine-rich repeat LGI family, member 3 |
chr2_-_50574856 | 2.17 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
chr5_+_7396141 | 2.15 |
ENST00000338316.4
|
ADCY2
|
adenylate cyclase 2 (brain) |
chr2_-_213403565 | 2.15 |
ENST00000342788.4
ENST00000436443.1 |
ERBB4
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
chr11_-_47374246 | 2.14 |
ENST00000545968.1
ENST00000399249.2 ENST00000256993.4 |
MYBPC3
|
myosin binding protein C, cardiac |
chr9_-_101471479 | 2.10 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr13_-_25746416 | 2.10 |
ENST00000515384.1
ENST00000357816.2 |
AMER2
|
APC membrane recruitment protein 2 |
chr1_+_95582881 | 2.10 |
ENST00000370203.4
ENST00000456991.1 |
TMEM56
|
transmembrane protein 56 |
chr2_+_207308220 | 2.03 |
ENST00000264377.3
|
ADAM23
|
ADAM metallopeptidase domain 23 |
chr10_+_115803650 | 1.94 |
ENST00000369295.2
|
ADRB1
|
adrenoceptor beta 1 |
chr3_+_11034403 | 1.92 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr9_-_93405352 | 1.88 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr3_+_85008089 | 1.85 |
ENST00000383699.3
|
CADM2
|
cell adhesion molecule 2 |
chr11_-_61348576 | 1.83 |
ENST00000263846.4
|
SYT7
|
synaptotagmin VII |
chr5_+_161274685 | 1.83 |
ENST00000428797.2
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
chr5_+_152870106 | 1.71 |
ENST00000285900.5
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
chr18_-_70535177 | 1.69 |
ENST00000327305.6
|
NETO1
|
neuropilin (NRP) and tolloid (TLL)-like 1 |
chr10_+_25463951 | 1.66 |
ENST00000376351.3
|
GPR158
|
G protein-coupled receptor 158 |
chr19_+_589893 | 1.66 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
chr5_+_79331164 | 1.66 |
ENST00000350881.2
|
THBS4
|
thrombospondin 4 |
chr1_-_31712401 | 1.63 |
ENST00000373736.2
|
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
chr6_-_46293378 | 1.61 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
chrX_+_152953505 | 1.61 |
ENST00000253122.5
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8 |
chr4_-_141348999 | 1.58 |
ENST00000325617.5
|
CLGN
|
calmegin |
chr20_-_48099182 | 1.58 |
ENST00000371741.4
|
KCNB1
|
potassium voltage-gated channel, Shab-related subfamily, member 1 |
chr11_+_22359562 | 1.57 |
ENST00000263160.3
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6 |
chr12_+_5019061 | 1.57 |
ENST00000382545.3
|
KCNA1
|
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) |
chr6_-_90121938 | 1.56 |
ENST00000369415.4
|
RRAGD
|
Ras-related GTP binding D |
chr20_+_24449821 | 1.56 |
ENST00000376862.3
|
SYNDIG1
|
synapse differentiation inducing 1 |
chr4_-_53525406 | 1.55 |
ENST00000451218.2
ENST00000441222.3 |
USP46
|
ubiquitin specific peptidase 46 |
chr2_-_166930131 | 1.54 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
chr20_-_656823 | 1.53 |
ENST00000246104.6
|
SCRT2
|
scratch family zinc finger 2 |
chr14_+_72399833 | 1.51 |
ENST00000553530.1
ENST00000556437.1 |
RGS6
|
regulator of G-protein signaling 6 |
chr6_-_166796461 | 1.51 |
ENST00000360961.6
ENST00000341756.6 |
MPC1
|
mitochondrial pyruvate carrier 1 |
chr10_-_69455873 | 1.50 |
ENST00000433211.2
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3 |
chr9_-_19786926 | 1.48 |
ENST00000341998.2
ENST00000286344.3 |
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
chr1_-_211307315 | 1.47 |
ENST00000271751.4
|
KCNH1
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
chr1_+_110693103 | 1.46 |
ENST00000331565.4
|
SLC6A17
|
solute carrier family 6 (neutral amino acid transporter), member 17 |
chr8_-_40755333 | 1.46 |
ENST00000297737.6
ENST00000315769.7 |
ZMAT4
|
zinc finger, matrin-type 4 |
chr3_+_49591881 | 1.45 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr8_+_142402089 | 1.45 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
chr14_-_35182994 | 1.42 |
ENST00000341223.3
|
CFL2
|
cofilin 2 (muscle) |
chr2_-_158485387 | 1.39 |
ENST00000243349.8
|
ACVR1C
|
activin A receptor, type IC |
chr19_+_35521572 | 1.36 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr14_+_65171099 | 1.36 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr2_-_40679186 | 1.34 |
ENST00000406785.2
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr4_-_153457197 | 1.34 |
ENST00000281708.4
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr7_+_136553370 | 1.34 |
ENST00000445907.2
|
CHRM2
|
cholinergic receptor, muscarinic 2 |
chr22_-_33454354 | 1.32 |
ENST00000358763.2
|
SYN3
|
synapsin III |
chr20_-_32262165 | 1.31 |
ENST00000606690.1
ENST00000246190.6 ENST00000439478.1 ENST00000375238.4 |
NECAB3
|
N-terminal EF-hand calcium binding protein 3 |
chr11_+_24518723 | 1.31 |
ENST00000336930.6
ENST00000529015.1 ENST00000533227.1 |
LUZP2
|
leucine zipper protein 2 |
chr15_-_65809581 | 1.30 |
ENST00000341861.5
|
DPP8
|
dipeptidyl-peptidase 8 |
chr19_+_10527449 | 1.30 |
ENST00000592685.1
ENST00000380702.2 |
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
chr3_-_186080012 | 1.30 |
ENST00000544847.1
ENST00000265022.3 |
DGKG
|
diacylglycerol kinase, gamma 90kDa |
chr2_+_155554797 | 1.30 |
ENST00000295101.2
|
KCNJ3
|
potassium inwardly-rectifying channel, subfamily J, member 3 |
chr6_-_11044509 | 1.29 |
ENST00000354666.3
|
ELOVL2
|
ELOVL fatty acid elongase 2 |
chr5_-_83680603 | 1.29 |
ENST00000296591.5
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3 |
chr17_+_56833184 | 1.28 |
ENST00000308249.2
|
PPM1E
|
protein phosphatase, Mg2+/Mn2+ dependent, 1E |
chr1_-_47134101 | 1.26 |
ENST00000576409.1
|
ATPAF1
|
ATP synthase mitochondrial F1 complex assembly factor 1 |
chr11_+_119019722 | 1.26 |
ENST00000307417.3
|
ABCG4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr12_-_85306594 | 1.22 |
ENST00000266682.5
|
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15 |
chr3_+_42695176 | 1.22 |
ENST00000232974.6
ENST00000457842.3 |
ZBTB47
|
zinc finger and BTB domain containing 47 |
chr20_-_60982330 | 1.21 |
ENST00000279101.5
|
CABLES2
|
Cdk5 and Abl enzyme substrate 2 |
chr2_-_37193606 | 1.20 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
chr11_-_1593150 | 1.20 |
ENST00000397374.3
|
DUSP8
|
dual specificity phosphatase 8 |
chr3_+_20081515 | 1.20 |
ENST00000263754.4
|
KAT2B
|
K(lysine) acetyltransferase 2B |
chr2_+_157291953 | 1.19 |
ENST00000310454.6
|
GPD2
|
glycerol-3-phosphate dehydrogenase 2 (mitochondrial) |
chr11_-_45687128 | 1.19 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr3_-_33686743 | 1.17 |
ENST00000333778.6
ENST00000539981.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
chr15_+_90544532 | 1.17 |
ENST00000268154.4
|
ZNF710
|
zinc finger protein 710 |
chr9_-_134145880 | 1.17 |
ENST00000372269.3
ENST00000464831.1 |
FAM78A
|
family with sequence similarity 78, member A |
chr6_+_117586713 | 1.13 |
ENST00000352536.3
ENST00000326274.5 |
VGLL2
|
vestigial like 2 (Drosophila) |
chr1_-_146644122 | 1.13 |
ENST00000254101.3
|
PRKAB2
|
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
chr9_-_34523027 | 1.12 |
ENST00000399775.2
|
ENHO
|
energy homeostasis associated |
chr1_-_111150048 | 1.12 |
ENST00000485317.1
|
KCNA2
|
potassium voltage-gated channel, shaker-related subfamily, member 2 |
chr11_-_790060 | 1.12 |
ENST00000330106.4
|
CEND1
|
cell cycle exit and neuronal differentiation 1 |
chr9_-_111929560 | 1.11 |
ENST00000561981.2
|
FRRS1L
|
ferric-chelate reductase 1-like |
chr7_-_44530479 | 1.10 |
ENST00000355451.7
|
NUDCD3
|
NudC domain containing 3 |
chr14_+_53019822 | 1.10 |
ENST00000321662.6
|
GPR137C
|
G protein-coupled receptor 137C |
chr14_+_93897199 | 1.10 |
ENST00000553484.1
|
UNC79
|
unc-79 homolog (C. elegans) |
chr9_-_91793675 | 1.10 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
chr9_+_34990219 | 1.09 |
ENST00000541010.1
ENST00000454002.2 ENST00000545841.1 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr1_-_67266939 | 1.09 |
ENST00000304526.2
|
INSL5
|
insulin-like 5 |
chr5_+_10564432 | 1.09 |
ENST00000296657.5
|
ANKRD33B
|
ankyrin repeat domain 33B |
chr7_+_28452130 | 1.08 |
ENST00000357727.2
|
CREB5
|
cAMP responsive element binding protein 5 |
chr1_-_232697304 | 1.08 |
ENST00000366630.1
|
SIPA1L2
|
signal-induced proliferation-associated 1 like 2 |
chr11_-_88796803 | 1.07 |
ENST00000418177.2
ENST00000455756.2 |
GRM5
|
glutamate receptor, metabotropic 5 |
chr20_-_42939782 | 1.07 |
ENST00000396825.3
|
FITM2
|
fat storage-inducing transmembrane protein 2 |
chr5_-_107717058 | 1.07 |
ENST00000359660.5
|
FBXL17
|
F-box and leucine-rich repeat protein 17 |
chr1_-_193155729 | 1.05 |
ENST00000367434.4
|
B3GALT2
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
chr3_-_24536253 | 1.05 |
ENST00000428492.1
ENST00000396671.2 ENST00000431815.1 ENST00000418247.1 ENST00000416420.1 ENST00000356447.4 |
THRB
|
thyroid hormone receptor, beta |
chr11_+_64073699 | 1.05 |
ENST00000405666.1
ENST00000468670.1 |
ESRRA
|
estrogen-related receptor alpha |
chr7_-_74867509 | 1.04 |
ENST00000426327.3
|
GATSL2
|
GATS protein-like 2 |
chr8_-_145559943 | 1.04 |
ENST00000332135.4
|
SCRT1
|
scratch family zinc finger 1 |
chr8_-_53322303 | 1.03 |
ENST00000276480.7
|
ST18
|
suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein) |
chr16_+_68279207 | 1.03 |
ENST00000413021.2
ENST00000565744.1 ENST00000219345.5 |
PLA2G15
|
phospholipase A2, group XV |
chr19_-_17445613 | 1.02 |
ENST00000159087.4
|
ANO8
|
anoctamin 8 |
chr10_+_125425871 | 1.02 |
ENST00000284674.1
|
GPR26
|
G protein-coupled receptor 26 |
chr19_+_13135386 | 1.01 |
ENST00000360105.4
ENST00000588228.1 ENST00000591028.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr1_-_41131326 | 1.00 |
ENST00000372684.3
|
RIMS3
|
regulating synaptic membrane exocytosis 3 |
chr2_+_173940442 | 1.00 |
ENST00000409176.2
ENST00000338983.3 ENST00000431503.2 |
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
chr8_-_139509065 | 1.00 |
ENST00000395297.1
|
FAM135B
|
family with sequence similarity 135, member B |
chr1_+_231664390 | 0.99 |
ENST00000366639.4
ENST00000413309.2 |
TSNAX
|
translin-associated factor X |
chr14_+_93389425 | 0.99 |
ENST00000216492.5
ENST00000334654.4 |
CHGA
|
chromogranin A (parathyroid secretory protein 1) |
chr7_-_122526799 | 0.98 |
ENST00000334010.7
ENST00000313070.7 |
CADPS2
|
Ca++-dependent secretion activator 2 |
chr19_-_409134 | 0.98 |
ENST00000332235.6
|
C2CD4C
|
C2 calcium-dependent domain containing 4C |
chr2_+_162272605 | 0.98 |
ENST00000389554.3
|
TBR1
|
T-box, brain, 1 |
chr17_-_74236382 | 0.98 |
ENST00000592271.1
ENST00000319945.6 ENST00000269391.6 |
RNF157
|
ring finger protein 157 |
chr8_+_107670064 | 0.97 |
ENST00000312046.6
|
OXR1
|
oxidation resistance 1 |
chr8_-_114389353 | 0.96 |
ENST00000343508.3
|
CSMD3
|
CUB and Sushi multiple domains 3 |
chr20_-_42816206 | 0.94 |
ENST00000372980.3
|
JPH2
|
junctophilin 2 |
chr4_+_150999418 | 0.94 |
ENST00000296550.7
|
DCLK2
|
doublecortin-like kinase 2 |
chr11_-_132813566 | 0.93 |
ENST00000331898.7
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
chr16_+_28303804 | 0.93 |
ENST00000341901.4
|
SBK1
|
SH3 domain binding kinase 1 |
chr1_-_46598284 | 0.93 |
ENST00000423209.1
ENST00000262741.5 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr9_-_130890662 | 0.91 |
ENST00000277462.5
ENST00000338961.6 |
PTGES2
|
prostaglandin E synthase 2 |
chr20_+_8112824 | 0.90 |
ENST00000378641.3
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific) |
chr12_-_111021110 | 0.90 |
ENST00000354300.3
|
PPTC7
|
PTC7 protein phosphatase homolog (S. cerevisiae) |
chr5_-_131132614 | 0.89 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
chr1_+_42846443 | 0.89 |
ENST00000410070.2
ENST00000431473.3 |
RIMKLA
|
ribosomal modification protein rimK-like family member A |
chr12_+_109490370 | 0.88 |
ENST00000257548.5
ENST00000536723.1 ENST00000536393.1 |
USP30
|
ubiquitin specific peptidase 30 |
chr4_+_41362796 | 0.88 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr3_-_9291063 | 0.88 |
ENST00000383836.3
|
SRGAP3
|
SLIT-ROBO Rho GTPase activating protein 3 |
chr19_+_47104493 | 0.87 |
ENST00000291295.9
ENST00000597743.1 |
CALM3
|
calmodulin 3 (phosphorylase kinase, delta) |
chr1_+_220701456 | 0.85 |
ENST00000366918.4
ENST00000402574.1 |
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
chr7_+_97736197 | 0.85 |
ENST00000297293.5
|
LMTK2
|
lemur tyrosine kinase 2 |
chr1_-_72748417 | 0.84 |
ENST00000357731.5
|
NEGR1
|
neuronal growth regulator 1 |
chrX_+_113818545 | 0.84 |
ENST00000371951.1
ENST00000276198.1 ENST00000371950.3 |
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
chr16_+_11762270 | 0.84 |
ENST00000329565.5
|
SNN
|
stannin |
chr14_+_79745746 | 0.84 |
ENST00000281127.7
|
NRXN3
|
neurexin 3 |
chr1_-_149982624 | 0.84 |
ENST00000417191.1
ENST00000369135.4 |
OTUD7B
|
OTU domain containing 7B |
chr21_+_45285050 | 0.84 |
ENST00000291572.8
|
AGPAT3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr6_-_55443975 | 0.83 |
ENST00000308161.4
ENST00000398661.2 ENST00000274901.4 |
HMGCLL1
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1 |
chr6_+_69345166 | 0.83 |
ENST00000370598.1
|
BAI3
|
brain-specific angiogenesis inhibitor 3 |
chr10_-_735553 | 0.82 |
ENST00000280886.6
ENST00000423550.1 |
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
chr4_-_122854612 | 0.82 |
ENST00000264811.5
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3 |
chr13_-_110438914 | 0.82 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chr18_-_30050395 | 0.81 |
ENST00000269209.6
ENST00000399218.4 |
GAREM
|
GRB2 associated, regulator of MAPK1 |
chr5_-_57756087 | 0.80 |
ENST00000274289.3
|
PLK2
|
polo-like kinase 2 |
chr2_-_180726232 | 0.79 |
ENST00000410066.1
|
ZNF385B
|
zinc finger protein 385B |
chr20_-_43438912 | 0.78 |
ENST00000541604.2
ENST00000372851.3 |
RIMS4
|
regulating synaptic membrane exocytosis 4 |
chr4_-_142053952 | 0.78 |
ENST00000515673.2
|
RNF150
|
ring finger protein 150 |
chr5_-_133968529 | 0.78 |
ENST00000402673.2
|
SAR1B
|
SAR1 homolog B (S. cerevisiae) |
chr22_+_50781723 | 0.77 |
ENST00000359139.3
ENST00000395741.3 ENST00000395744.3 |
PPP6R2
|
protein phosphatase 6, regulatory subunit 2 |
chr11_+_12695944 | 0.77 |
ENST00000361905.4
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr3_-_126076264 | 0.76 |
ENST00000296233.3
|
KLF15
|
Kruppel-like factor 15 |
chrX_+_28605516 | 0.75 |
ENST00000378993.1
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1 |
chr2_-_197457335 | 0.75 |
ENST00000260983.3
|
HECW2
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
chr11_-_117667806 | 0.75 |
ENST00000527706.1
ENST00000321322.6 |
DSCAML1
|
Down syndrome cell adhesion molecule like 1 |
chr20_+_44657845 | 0.74 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr20_-_5931109 | 0.73 |
ENST00000203001.2
|
TRMT6
|
tRNA methyltransferase 6 homolog (S. cerevisiae) |
chr20_-_55841662 | 0.72 |
ENST00000395863.3
ENST00000450594.2 |
BMP7
|
bone morphogenetic protein 7 |
chr4_+_93225550 | 0.72 |
ENST00000282020.4
|
GRID2
|
glutamate receptor, ionotropic, delta 2 |
chr5_-_59189545 | 0.72 |
ENST00000340635.6
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr12_+_51985001 | 0.71 |
ENST00000354534.6
|
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
chr4_+_144106080 | 0.71 |
ENST00000307017.4
|
USP38
|
ubiquitin specific peptidase 38 |
chr15_-_55881135 | 0.71 |
ENST00000302000.6
|
PYGO1
|
pygopus family PHD finger 1 |
chr8_-_92053212 | 0.71 |
ENST00000285419.3
|
TMEM55A
|
transmembrane protein 55A |
chr14_+_102829300 | 0.71 |
ENST00000359520.7
|
TECPR2
|
tectonin beta-propeller repeat containing 2 |
chr17_+_11924129 | 0.70 |
ENST00000353533.5
ENST00000415385.3 |
MAP2K4
|
mitogen-activated protein kinase kinase 4 |
chr8_-_105601134 | 0.70 |
ENST00000276654.5
ENST00000424843.2 |
LRP12
|
low density lipoprotein receptor-related protein 12 |
chr22_+_29876197 | 0.70 |
ENST00000310624.6
|
NEFH
|
neurofilament, heavy polypeptide |
chr9_-_14693417 | 0.69 |
ENST00000380916.4
|
ZDHHC21
|
zinc finger, DHHC-type containing 21 |
chr8_-_103251274 | 0.69 |
ENST00000251810.3
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible) |
chr6_+_96463840 | 0.69 |
ENST00000302103.5
|
FUT9
|
fucosyltransferase 9 (alpha (1,3) fucosyltransferase) |
chr9_-_28670283 | 0.69 |
ENST00000379992.2
|
LINGO2
|
leucine rich repeat and Ig domain containing 2 |
chr10_-_102989551 | 0.69 |
ENST00000370193.2
|
LBX1
|
ladybird homeobox 1 |
chr5_+_127419449 | 0.69 |
ENST00000262461.2
ENST00000343225.4 |
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2 |
chr2_+_86947296 | 0.68 |
ENST00000283632.4
|
RMND5A
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
chr12_-_31744031 | 0.68 |
ENST00000389082.5
|
DENND5B
|
DENN/MADD domain containing 5B |
chr1_+_214161272 | 0.67 |
ENST00000498508.2
ENST00000366958.4 |
PROX1
|
prospero homeobox 1 |
chr7_-_117513540 | 0.67 |
ENST00000160373.3
|
CTTNBP2
|
cortactin binding protein 2 |
chr1_-_153919128 | 0.67 |
ENST00000361217.4
|
DENND4B
|
DENN/MADD domain containing 4B |
chr15_+_33603147 | 0.65 |
ENST00000415757.3
ENST00000389232.4 |
RYR3
|
ryanodine receptor 3 |
chr2_+_198380289 | 0.65 |
ENST00000233892.4
ENST00000409916.1 |
MOB4
|
MOB family member 4, phocein |
chr3_-_119813264 | 0.64 |
ENST00000264235.8
|
GSK3B
|
glycogen synthase kinase 3 beta |
chr16_-_2264779 | 0.63 |
ENST00000333503.7
|
PGP
|
phosphoglycolate phosphatase |
chr7_+_110731062 | 0.63 |
ENST00000308478.5
ENST00000451085.1 ENST00000422987.3 ENST00000421101.1 |
LRRN3
|
leucine rich repeat neuronal 3 |
chr5_-_38595498 | 0.63 |
ENST00000263409.4
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chr12_+_79258547 | 0.62 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr12_-_10875831 | 0.62 |
ENST00000279550.7
ENST00000228251.4 |
YBX3
|
Y box binding protein 3 |
chr13_-_21476900 | 0.62 |
ENST00000400602.2
ENST00000255305.6 |
XPO4
|
exportin 4 |
chr4_+_26585538 | 0.62 |
ENST00000264866.4
|
TBC1D19
|
TBC1 domain family, member 19 |
chr2_-_33824336 | 0.61 |
ENST00000431950.1
ENST00000403368.1 ENST00000441530.2 |
FAM98A
|
family with sequence similarity 98, member A |
chr5_+_63802109 | 0.61 |
ENST00000334025.2
|
RGS7BP
|
regulator of G-protein signaling 7 binding protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.8 | 2.5 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.7 | 2.1 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.6 | 1.9 | GO:0003099 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.5 | 1.6 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.5 | 1.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.5 | 1.4 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.5 | 1.8 | GO:1990927 | vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.4 | 2.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 1.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.4 | 1.6 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.4 | 1.5 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.4 | 0.7 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
0.3 | 1.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.3 | 1.7 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 | 1.0 | GO:1901899 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
0.3 | 2.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.3 | 0.9 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 1.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.9 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 2.8 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.3 | 4.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 2.7 | GO:0015820 | leucine transport(GO:0015820) |
0.3 | 1.3 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.3 | 1.0 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.3 | 1.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.7 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.2 | 2.2 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.2 | 1.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.2 | 1.7 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.2 | 0.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.3 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.7 | GO:0061114 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.2 | 0.9 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.2 | 1.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 1.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.6 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.2 | 0.8 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.2 | 1.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 0.6 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.2 | 2.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.2 | 1.0 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 1.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.2 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 1.6 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.2 | 0.5 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.2 | 1.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.2 | 2.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.5 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 1.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 1.1 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.2 | 0.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 1.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.5 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.1 | 1.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.7 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.4 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.1 | 2.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 2.3 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 1.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 1.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 1.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.6 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.1 | 1.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.3 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
0.1 | 0.6 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 1.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.8 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 1.0 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.3 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.1 | 1.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 1.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 1.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 1.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.3 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.1 | 1.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.1 | 1.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.7 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 0.5 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 0.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 0.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 2.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.8 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.4 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 1.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 1.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 1.3 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.7 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.0 | 0.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 1.1 | GO:1902001 | carnitine shuttle(GO:0006853) fatty acid transmembrane transport(GO:1902001) |
0.0 | 1.7 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.2 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.0 | 0.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.6 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 1.0 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.1 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.0 | 1.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 1.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 1.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.0 | 0.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 1.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 1.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.4 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 1.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 1.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.4 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.7 | GO:0086010 | neuronal action potential(GO:0019228) membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.0 | 0.1 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 1.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.5 | GO:0048864 | stem cell development(GO:0048864) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 1.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.8 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.7 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.4 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:0048255 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.0 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 1.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 1.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 1.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.9 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 1.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 1.4 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 2.0 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 1.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.7 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 1.7 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 1.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0098855 | HCN channel complex(GO:0098855) |
0.5 | 2.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 2.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.4 | 2.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 1.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 3.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 1.7 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 1.6 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.7 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 1.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 3.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.2 | 4.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 1.8 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.7 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 4.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.5 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 0.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 1.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.3 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 1.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.1 | 0.3 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.1 | 1.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 1.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 2.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 2.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 3.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.7 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 5.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 1.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 1.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.5 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 3.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 4.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 4.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.1 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.0 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 2.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 1.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 1.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.0 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.2 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.8 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.8 | 3.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.6 | 1.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.5 | 1.6 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.5 | 1.4 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 1.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.4 | 2.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.4 | 1.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.4 | 3.5 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.3 | 1.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.3 | 1.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.3 | 1.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 2.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 1.2 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.2 | 1.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 1.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.7 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.2 | 0.8 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.2 | 1.3 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.2 | 1.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.2 | 5.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.1 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.2 | 3.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.8 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.2 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.2 | 1.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 1.9 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 1.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.1 | 2.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 2.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.3 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.1 | 1.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 0.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 1.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.8 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 1.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 2.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 4.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 2.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.5 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 1.6 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 3.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 1.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 4.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.4 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 2.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 1.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 3.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 1.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 3.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 4.2 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.0 | 1.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 2.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.7 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 2.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 1.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 1.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 1.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 1.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 1.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.2 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 3.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 2.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 2.0 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 2.0 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 2.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 2.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 4.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 5.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 2.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 5.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 3.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 1.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 2.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 2.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |